Barclays PLC
17 October 2005
17 October 2005
Director/PDMR shareholding: Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b)
The Company was notified on 14 October 2005 by Personal Equity Plan (PEP) /
Individual Savings Account (ISA) Administrators that on 14 October 2005 the
following director (or his connected persons) had received ordinary shares in
the Company, following the reinvestment of the Barclays dividend for the half
year ended 30 June 2005, at a price of 546.5p per share. The number of shares
received, together with his total beneficial interest following the allotments
are as follows:
Director / PDMR No. of shares received Beneficial interest
GA Hoffman 159 172,645
In addition to these transactions, the trustees of all the Barclays Group
employees' benefit trusts hold a total of 149,901,225 ordinary shares in
Barclays PLC. GA Hoffman, the Chairman, and the executive directors of Barclays
PLC are amongst the potential beneficiaries under these trusts and are therefore
regarded for Companies Act purposes as being interested in the Barclays PLC
ordinary shares held in them.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.